Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey.

[1]  A. Humar.  Donor and recipient outcomes after adult living donor liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  H. Kiyokawa,et al.  Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening , 2003, Vox sanguinis.

[3]  Christian Gluud,et al.  Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. , 2003, JAMA.

[4]  William M. Lee.  Acute Liver Failure in the United States , 2003, Annals of Internal Medicine.

[5]  Kazuyuki Suzuki,et al.  Fulminant hepatitis E in Japan. , 2002, The New England journal of medicine.

[6]  H. Hirasawa,et al.  Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure , 2001, Critical care medicine.

[7]  O. Yokosuka,et al.  Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: analyses by nucleic acid amplification method. , 1998, The Journal of infectious diseases.

[8]  J. Rosenblatt,et al.  Acute hepatitis E by a new isolate acquired in the United States. , 1997, Mayo Clinic proceedings.

[9]  J. Neuberger,et al.  Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. , 1997, Journal of hepatology.

[10]  Kazuaki Inoue,et al.  Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. , 2008, Artificial organs.

[11]  F. Ueno,et al.  Interferon therapy for fulminant hepatitis associated with precore region mutation in hepatitis B virus carrier. , 1996, The American journal of gastroenterology.

[12]  S. Kleinman,et al.  The Risk of Transfusion-Transmitted Viral Infections , 1996 .

[13]  M. Monden,et al.  Quality of life in adult Japanese patients undergoing liver transplants overseas. , 1996, Transplantation proceedings.

[14]  H. Yoshizawa.  Blood screening to prevent post-transfusion hepatitis in Japan: effective for prevention as well as revealing for epidemiology of HBV and HCV infection in healthy subjects , 1996 .

[15]  T. Kuroki,et al.  Does GBV-C cause fulminant hepatitis in Japan? , 1996, The Lancet.

[16]  S. Mishiro,et al.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology , 1995, The Lancet.

[17]  C. Yang,et al.  Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients. , 1995, Nephron.

[18]  H. Okamoto,et al.  Contribution of hepatitis C virus to non‐A, non‐B fulminant hepatitis in Japan , 1994, Hepatology.

[19]  K. Lenz,et al.  Prognostic indicators in fulminant hepatic failure. , 1992, Zeitschrift fur Gastroenterologie.

[20]  L. Ferrell,et al.  Hepatitis B virus and apparent fulminant non-A, non-B hepatitis , 1992, The Lancet.

[21]  Japanese Red Cross Non-A.  Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis , 1991 .

[22]  J. Roberts,et al.  Hepatitis C virus not found in fulminant non-A, non-B hepatitis. , 1991, Annals of internal medicine.

[23]  A. Lok,et al.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. , 1991 .

[24]  R Williams,et al.  Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.

[25]  K. Shiraki,et al.  National Project on the Prevention of Mother‐to‐Infant Infection by Hepatitis B Virus in Japan , 1988, Acta paediatrica Japonica : Overseas edition.

[26]  Y. Joshi,et al.  Acute liver failure. Experience with 145 patients. , 1986, Journal of clinical gastroenterology.

[27]  J. Ludwig,et al.  Fulminant hepatitis: Mayo Clinic experience with 34 cases. , 1985, Mayo Clinic proceedings.

[28]  M. Richards,et al.  Aetiology of fatal viral hepatitis in Melbourne: A retrospective study , 1984, Medical Journal of Australia.

[29]  G. Papaevangelou,et al.  Etiology of Fulminant Viral Hepatitis in Greece , 1984, Hepatology.

[30]  E. Christensen,et al.  Prediction of fatality in fulminant hepatic failure. , 1984, Scandinavian journal of gastroenterology.

[31]  Y. Takahashi,et al.  Acute hepatic failure. , 1975, The Central African journal of medicine.

[32]  W. Bancroft,et al.  IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus. , 1981, The Journal of infectious diseases.

[33]  J. Horney,et al.  The liver during and after fulminant hepatitis. , 1977, Gastroenterology.

[34]  H. Greenberg.  Progress in Liver Disease , 1970 .

[35]  C. S. Davidson,et al.  The management of fulminant hepatic failure. , 1970, Progress in liver diseases.